Related by context. All words. (Click for frequent words.) 67 HIV maturation inhibition 65 apricitabine ATC 65 SCIB1 65 immunotherapeutic approaches 65 TRIOLEX HE# 64 oral ghrelin agonist 64 IMPDH inhibitor 64 fusion inhibitor 63 ALN PCS 63 TRIOLEX TM HE# 63 next generation URAT1 63 novel therapeutic antibodies 63 maturation inhibitor 63 therapeutic monoclonal antibody 63 commercialize deforolimus ARIAD 63 HuCAL antibodies 62 ZFP Therapeutics 62 pegylated interferon lambda 62 dimebon latrepirdine 62 HuMax TAC 62 P#X# antagonist 62 novel L DOS# 62 MolecularBreeding 62 HEPLISAV TM hepatitis B 61 Micromet proprietary BiTE 61 AVAX AC Vaccine 61 CCR9 antagonist 61 recombinant influenza 61 rotavirus shingles 61 XL# anticancer compounds 61 THR beta agonist 61 PORxin TM 61 TBC# 61 oncolytic virus therapies 60 deCODE AF TM 60 Albuferon albinterferon alfa 2b 60 treats acute lymphoblastic 60 progressive metastatic prostate 60 IMiDs ® 60 Archexin 60 acyclovir Lauriad R 60 VitiGam 60 targeted radiotherapeutic 60 Fc fusion protein 60 proprietary BiTE ® 60 accumulate preferentially 60 platinum chemotherapeutic 60 purinergic receptors P#X# 59 Vicriviroc 59 therapeutic monoclonal antibodies 59 Crofelemer budesonide foam 59 selective angiogenic kinase inhibitor 59 myasthenia gravis Huntington 59 therapeutic peptide 59 skeletal sarcomere activators 59 IMA# 59 Provectus Pharmaceuticals specializes 59 commercialize CorMedix drug 59 Chimigen TM 59 Personalized Immunotherapy 59 inhibit metastasis 59 anti CD3 monoclonal 59 carcinoid syndrome diabetes 59 Surfaxin LS 59 mSEPT9 biomarker 59 rheumatoid arthritis thrombocytopenia 59 CCR5 receptor antagonist 59 molecular chaperone regulation 59 MediGene focuses 59 DGAT1 inhibitors 59 ViroChem 59 rxRNA 59 ImmunoGen TAP technology 59 inflammatory autoimmune diseases 59 staphylococcal vaccine 59 Prodarsan R 59 AeroLEF R 59 Kosan dependence 59 TELINTRA R 59 tubulin inhibitor 58 aldehyde dehydrogenase ALDH2 deficiency 58 Nanobody R 58 generation URAT1 inhibitor 58 fusion enhancers 58 siRNA therapeutic 58 TransVax tm 58 serious systemic Staphylococcal 58 SinuNase ™ 58 novel peptides 58 candidate REP# 58 ChronVac C R 58 OncoVex 58 LymphoStat B TM 58 systemic RNAi 58 PNP inhibitor 58 HTS assay 58 gastro intestinal inflammation 58 CYT# potent vascular disrupting 58 Maxy G# 58 HepDirect R 58 flu mAb 58 specific ZFP Nucleases 58 HEPLISAV ™ 58 targeting PCSK9 58 DNA RNA Medicines 58 Ostabolin C TM 58 APOPTONE TM HE# 58 mGluR2 NAM 58 generation PNP inhibitor 58 beta secretase inhibitors 58 anticancer therapeutics 58 Sangamo ZFP technology 58 Sphingomab TM 58 BiTE antibodies represent 58 PEGylated interferon 58 TransVax ™ 58 recombinant biopharmaceutical 58 LEAPS TM 58 recombinant protective 58 Smac mimetics 58 Selective Electrochemical Tumor Ablation 58 TRIOLEX HE# APOPTONE HE# 58 ELND-#/AZD-# 58 HIV integrase inhibitors 58 Nasdaq MITI biopharmaceutical 58 Spiegelmer ® 58 novel immunotherapies 58 AKT inhibitor 58 budesonide MMX Phase III 58 GPR# agonist 58 diabetes irritable bowel 58 metaglidasen 58 Cathepsin S 58 mGluR5 PAM 58 Crucell genetically engineered 58 delivery polymer matrix 58 patented DepoVax TM 58 anthrax botulism typhoid 58 Spiegelmer 58 SynCon 58 sodium glucose transporter 58 MVA BN R 57 Curaxin 57 glucokinase activator 57 ONCONASE R 57 Protexia ® 57 lipid nanoparticle 57 CYT# vascular disrupting 57 DPX Survivac 57 OncoVEX 57 Sphingomab 57 TRO# 57 OraQuick ® 57 Neo Kidney Augment ™ 57 visit www.genenews.com 57 AcryMed technologies 57 BHT DNA 57 Oral NKTR 57 Fleximer 57 CD# CEA 57 isoform selective 57 AGS PSCA 57 DepoVax ™ 57 kidney urologic 57 HQK 57 TOCOSOL Camptothecin 57 polymer conjugate technology 57 Isis antisense 57 candidate volociximab 57 influenza hypercholesterolemia 57 PDE4 modulators 57 Annamycin 57 HDL Selective Delipidation 57 cathepsin K inhibitor 57 adrenergic regulation 57 R#/MEM # 57 oral NKTR 57 anthrax botulism tuberculosis typhoid 57 staphylococcal vaccines 57 commercialize deforolimus 57 inhibit replication 57 subsidiaries visit http:/www.apricusbio.com 57 AcryMed Incorporated 57 RADCOM specializes 57 biomarkers predictive 57 Hedgehog antagonist 57 HIV coinfected 57 smallpox vaccine IMVAMUNE R 57 molecular imaging radiopharmaceutical 57 XL# XL# XL# XL# 57 noninvasive prenatal diagnostic 57 delta opioid receptor 57 promising anticancer 57 ASG 5ME 57 vigabatrin GABA aminotransferase inhibitor 57 Canvaxin TM 57 TLR9 agonist 57 Sopherion 57 candidate ATHX 57 CCR2 antagonists 57 PDE# 57 AdhTAP 57 motexafin gadolinium Injection 57 ALN TTR 56 Onconase 56 ASONEP TM 56 patented DepoVax ™ 56 Epigenomics proprietary 56 3 registrational trial 56 IMiDs R 56 Pertuzumab 56 Tarvacin Anti Cancer 56 HCV polymerase 56 APOPTONE ™ 56 OMP #R# 56 nucleoside tide 56 initiate Phase 2b 56 Acetavance TM intravenous acetaminophen 56 ENABLE Phase 2 56 TRIOLEX ™ 56 Intravenous CP 56 advanced compound INCB# 56 Microbix specializes 56 PDE4 inhibitor 56 Aganocide ® 56 Zavesca r 56 antisense drug 56 predictive toxicology 56 cellular immunotherapy 56 potentially treat nephropathic 56 epothilone 56 potent suppressor 56 oral proteasome inhibitor 56 Galenea 56 apply Enhanze technology 56 OvaRex R 56 IMC #B 56 intranasal insulin product 56 Panzem R 56 EC Cysteamine 56 androgen receptor antagonist 56 MKC# MT 56 MassARRAY ® 56 AdVac 56 lysophosphatidic acid LPA 56 sirtuin therapeutics 56 Antibody Drug Conjugate 56 semi synthetic lipoglycopeptide 56 VitiGam TM 56 hepatitis C HCV 56 CDAD Clostridium difficile 56 nucleotide analog 56 protective antigen rPA 56 Charlesson 56 Panzem ® 56 topical agent Xantryl 56 MedMira rapid 56 AFFITOME R 56 pharmacological chaperone 56 lintuzumab SGN 56 immunotherapeutic vaccine 56 MAXY VII 56 CRO IBS 56 ZOLL resuscitation product 56 CINQUIL 56 Xcytrin R 56 TNFerade ™ 56 DIFICID ™ 56 PI3K/Akt pathway inhibitor 56 SynCon ™ 56 Nicotine Conjugate Vaccine 56 Evoltra ® 56 AN# novel 56 small molecule glucokinase 56 Selzentry maraviroc 56 sapacitabine CYC# 56 deforolimus 56 CORT # 56 Pimavanserin 56 PF # [002] 56 Co Receptor Tropism 56 Hepatitis C Virus HCV 56 REGEN trial 56 INTERCEPT red 56 Syncria 56 BCR ABL inhibitor 56 MCSP respectively 56 romazarit 56 PEG irinotecan 56 selective immunoproteasome inhibitor 56 tablet purgative preparation 56 TKM PLK1 56 oral picoplatin 56 adrenal steroid hormones 56 MKC# 56 antigen rPA anthrax 56 PANVAC VF 56 LEVADEX ™ 56 EGMI develops sales 56 Alzhemed TM 56 SGLT Inhibitors 56 therapeutic mAbs 56 SuperAntibody 56 vivo preclinical 56 psoriasis Crohn disease 56 HepeX B 56 recombinant antibodies 56 Ligand utilizes 56 successfully commercialize Iluvien 56 seliciclib CYC# 55 operable node 55 XOMA 3AB 55 TransVax 55 cMET inhibitor 55 immunotoxin 55 ALN RSV program 55 HuMax 55 Olaparib 55 oral PTH 55 Ceragenin ™ 55 immuno therapeutic 55 GLP toxicology studies 55 NuroPro R 55 concerning CombinatoRx 55 ALK inhibitors 55 MSCRAMM 55 PI3K/mTOR 55 small molecule PEGylation 55 immune modulating 55 GRN# 55 oral prodrug 55 Solazed 55 Micromet BiTE 55 CMV vaccine 55 NTDDS 55 XmAb ® 55 Aganocide 55 muscarinic receptor agonists 55 XmAb 55 HCV polymerase inhibitors 55 MiraCare TM Rapid 55 product Visicol R 55 Diamyd ® 55 commercialize NicVAX 55 selective estrogen receptor modulator 55 immatics 55 developing TB4 55 Epothilones 55 Panzem 55 AVI antisense 55 selectively modulate 55 proprietary PEGylation 55 Bellicum 55 RhuDex ® 55 Neugene 55 Phase lll 55 Hedgehog inhibitor 55 selective cannabinoid compounds 55 non nucleoside polymerase 55 AFREZZA ® 55 NurOwn 55 including eniluracil ADH 55 oral opioid modulator 55 PDE# inhibitors 55 OncoGel 55 personalized immunotherapy 55 antimitotic 55 RNA antagonists 55 PARI Pharma focuses 55 Fc engineered 55 enhance ApoA 55 JAK2 inhibitor 55 Phase 2a clinical trials 55 Exelixis compounds 55 pipeline GlycoPEG GCSF 55 Cardioxyl Pharmaceuticals 55 Daclizumab 55 var arrUrl = 55 maturation inhibitors 55 LHRH antagonist 55 confirmatory pivotal 55 DermaVir Patch 55 ospemifene 55 ART# 55 MAXY G# 55 InterfeRx TM 55 orally administered inhibitor 55 demonstrated anti amnesic 55 EVIZON TM squalamine lactate 55 davalintide 55 delipidation 55 MSCRAMM R 55 candidate KRN# 55 cMET 55 initiated Phase Ib 55 generation purine nucleoside 55 Apo AIMilano 55 Angiocept 55 Synavive ™ 55 Cx# [002] 55 using VIAdel TM 55 gastrointestinal GI perforations 55 InterfeRx 55 Captisol ® 55 biotherapeutic drugs 55 ApoB SNALP 55 CK # skeletal muscle 55 ErbB3 HER3 55 solanezumab 55 HCD# [002] 55 siRNA therapeutics 55 Plasma Converter TM 55 AMPK activators 55 LentiVector technology 55 cardio metabolic diseases 55 ZaBeCor 55 incyclinide 55 virologically suppressed 55 Allos retains exclusive 55 Insegia 55 ionotropic glutamate receptor antagonists 55 Neo Kidney Augment 55 Universal Pandemic Influenza 55 Vegenics 55 Antigen Express comprise immunotherapeutic 55 Factor VIIa 55 Generx TM 55 selective androgen receptor modulator 55 forodesine 55 MicuRx 55 novel antibody therapeutics 54 Cardioxyl 54 Inotek Pharmaceuticals Corporation 54 forodesine hydrochloride 54 Anavex #-# 54 leading oral taxane 54 Pradefovir 54 proprietary MSCRAMM protein 54 HuCAL antibody 54 candidate CRLX# 54 anthrax tuberculosis typhoid 54 activate SIRT1 54 factor VIIa 54 identify protein biomarkers 54 cyclophilin inhibitors 54 tiapamil 54 visit www.genmab.com 54 KNS # 54 Oncosphere System 54 Genz # 54 trap antimatter atoms 54 Receives Milestone Payment 54 Novartis NVS Snapshot Report 54 selectively induce apoptosis 54 Medarex UltiMAb R 54 IAP inhibitors 54 ImmuneY2 54 Innovive Pharmaceuticals 54 optical biosensors 54 Thiovir 54 Anticalins R 54 Enpath ability 54 synthetic retinoid 54 SmartChip TM product 54 Adnectin 54 bavituximab monotherapy trial 54 allosteric modulation 54 ALN VSP Phase 54 BCR ABL inhibitors 54 virus HCV protease inhibitor 54 ENMD # 54 potent activator 54 Myocet 54 cytomegalovirus CMV HAE 54 INTEGRILIN R eptifibatide Injection 54 BioLineRx advances 54 Tyzeka Sebivo 54 Fleximer R 54 Endotis 54 Diamyd R 54 Currently RegeneRx 54 CRACM 54 VentiRx 54 synDNA TM 54 Accelerated Intelligent 54 ® natalizumab 54 Affilin ® 54 #beta HSD1 54 proprietary biomaterials 54 skeletal sarcomere activator 54 relapsed leukemia 54 MR elastography 54 allosteric modulator 54 nucleotide analog polymerase inhibitor 54 commercialize OncoGenex lead 54 AERAS 54 Tumour Vascular Disrupting Agent 54 Zemplar Capsules 54 indications Cytokinetics 54 ALN VSP 54 Potelligent Technology 54 bioactive carbohydrates 54 NuMimetic TM 54 Alferon N 54 punctal plug delivery 54 ovarian cancer chronic hepatitis 54 Panzem R NCD 54 oral talactoferrin 54 selective receptor agonist 54 generation rPA anthrax 54 synthetic prions 54 Gnant consults 54 SynCon TM 54 Medarex UltiMAb Human 54 histone deacetylase HDAC inhibitors 54 Smac mimetic 54 Behcet uveitis 54 therapeutic radiopharmaceuticals 54 HCV protease inhibitors 54 multitargeted 54 telomerase inhibitor drug 54 Marqibo TM 54 midstage clinical 54 NexGenix 54 Troxatyl 54 Vicor anticipates 54 rPA vaccine candidate 54 HCV nucleoside polymerase inhibitors 54 Oxytrex TM 54 initiate multicenter 54 potent antiproliferative 54 technology visit www.energyconnectinc.com 54 commercialize XL# 54 PNT# 54 registrational trial 54 CCR5 antagonist 54 HIV protease inhibitor 54 HIV integrase inhibitor 54 regorafenib 54 anticancer antiviral 54 provides adenoviral reagents 54 selectively inhibited 54 innovative signaling pathway 54 biobetter 54 recombinant subunit vaccine 54 CRTH2 54 Mipomersen 54 multi kinase inhibitor 54 teplizumab 54 anticoagulant reversing agent 54 Prodarsan ® 54 signal transduction inhibitor 54 HCV protease inhibitor 54 novel immunomodulatory 54 PHX# 54 HDL mimetic 54 preclinical compounds 54 Virulizin ® 54 XmAb# 54 calcium phosphate nanotechnology CaP 54 cholesteryl ester transfer 54 EGS# 54 molecular therapeutics immunotherapies 54 men bisexuals transgender 54 EndoTAG TM 54 NS5A 54 ALS #-# 54 GMX# 54 liposomal formulation 54 Zemiva TM 53 PAION AG ISIN 53 CFTR inhibitors 53 BioFocus DPI Galapagos 53 antisense inhibitors 53 ASONEP ™ 53 ADCC enhanced 53 AVI antiviral programs 53 Kosan motilin agonist 53 AEG# 53 Monogram Trofile Assay 53 proprietary electroporation 53 Albugon 53 Bilive TM 53 cytomegalovirus infections 53 muscarinic receptor agonist 53 rALLy clinical trial 53 AdVac R 53 HUMIRA resembles 53 Cytolin ® 53 hepatitis C protease inhibitor 53 anti TNFa 53 proprietary intranasal insulin 53 HCV antiviral 53 YONDELIS R 53 MKC# MKC# PP 53 molecular imaging radiopharmaceuticals 53 NADiA 53 Pancreate 53 GED aPC 53 TRAIL receptor antibodies 53 PER.C6 ® production 53 blood clot dissolver 53 Prednisporin 53 beta secretase inhibitor 53 OMP #M# 53 vascular disrupting agent 53 Solazed TM 53 inflammation autoimmune diseases 53 Presents Preclinical 53 Ozarelix 53 commercialize Dimebon 53 theranostic 53 Avian Transgenic Technology 53 exome capture 53 GALNS 53 induced mucositis 53 Novartis Tasigna 53 DOS# 53 Nektar proprietary 53 LNP formulations 53 ALN TTR# 53 protein biochip 53 Inc. Nasdaq INFI 53 HyperAcute 53 non nucleoside HCV 53 Nanobody ® 53 ® alprostadil 53 small molecule tyrosine 53 Thalomid R 53 IGN# 53 mGluR4 activation 53 Ampakine compounds 53 Cytolin R 53 developing Surfactant Therapies 53 UltiMAb 53 class mGluR5 inhibitor 53 ProMune 53 MEK inhibitor 53 IoGen ™ 53 Tesetaxel 53 drug pipeline TAFA# 53 LHRH receptor positive 53 CCR5 antagonists 53 Tarvacin TM 53 vidofludimus 53 NEUGENE R 53 MOR# 53 Inc CRIS 53 Immunotherapies 53 renin inhibitors 53 Ceflatonin 53 vosaroxin 53 GVAX cancer 53 JAK inhibitors 53 VSEL technology 53 platforms GVAX 53 inhaled liposomal ciprofloxacin 53 Raf kinase inhibitor 53 Omthera 53 TaiGen 53 KinomeScan 53 Alnylam #x# 53 Diamyd r 53 vitro ADME 53 develop electroporation 53 Posiphen TM 53 behavioral neurobiology 53 Lixivaptan 53 epigenetic therapies 53 biochemical profiling 53 Project Boveri Find 53 Delafloxacin 53 Rexahn licensees 53 Anticalin R 53 novel antiviral therapeutics 53 BLyS specific 53 Synageva 53 Invader chemistry 53 humanized mouse 53 CombinatoRx proprietary 53 proprietary BiTE antibody 53 Ragweed Allergy 53 commercialize MDV# 53 Alzheimer disease cognitive dysfunction 53 AFFiRiS 53 Trofex TM 53 Receive Milestone Payment 53 treating psychiatric disorders 53 Dyax phage display 53 Acetylon 53 mGluR4 PAM 53 alvespimycin 53 torezolid phosphate 53 Alexza Staccato 53 Stapled Peptide 53 Nabi HB 53 transcutaneous immunization TCI 53 ghrelin antagonist 53 Inc. http:/www.QuigleyPharma.com conducts 53 Vaxfectin R adjuvant 53 drug conjugate ADC 53 SNS# T 53 Zacharon 53 clinically differentiated 53 endothelin antagonist 53 immunotherapeutic 53 Phylomer ® 53 Etubics 53 volociximab 53 please visit http:/www.sunesis.com 53 Novosom 53 evaluating Actimmune 53 P2V TM 53 Nanobodies ® 53 Profectus BioSciences 53 PDX pralatrexate novel 53 GATTEX teduglutide 53 migraine headaches neuropathic pain 53 technology visit http:/www.genmab.com 53 Pagoclone 53 mertansine 53 YONDELIS 52 valopicitabine NM# 52 FastScale Technology delivers 52 CG# [003] 52 Nanobody 52 CRD5 52 virology Progenics 52 Lisofylline LSF 52 Affimed 52 Allovectin 7 52 GSK '# 52 MassARRAY platform 52 molecular diagnostic assays 52 KRYSTEXXA TM pegloticase 52 Phase III ADT 52 VeraTag technology 52 OvaRex 52 Bioral Amphotericin B 52 drug conjugate 52 pimavanserin ACADIA 52 visit http:/www.neogenomics.org 52 oxidative stress induction 52 CoLucid 52 licensed Rituxan Herceptin 52 neuro inflammatory 52 recovers cellulosic biomass 52 Syntonix 52 StemEx R 52 nebulized budesonide 52 peptidomimetic 52 Onko Sure ™ 52 POWERSTACK tm MC# 52 SNT MC# 52 GLPG# 52 ReN# stem cell 52 Dapagliflozin 52 enGene 52 Viamet 52 CRMD# 52 Phase #b/#a trial 52 highly selective endothelin 52 JAK inhibitor 52 epilepsy neuropathic pain 52 regenerative therapeutics programs 52 ReN# 52 dextofisopam 52 ZFP technology 52 viral protease 52 NASDAQ INFI 52 Medarex UltiMAb 52 pafuramidine maleate 52 Imec performs world 52 iBioLaunch platform 52 Nasdaq PANC biotechnology 52 KuDOS 52 synDNA 52 proteasome inhibitor 52 OXIGON TM 52 Telatinib 52 BCX# 52 Targeted Chemotherapy 52 Provecta TM 52 Visit www.BASInc.com 52 preclinical efficacy 52 Aurora kinase inhibitor 52 Vaxfectin ® 52 Group SolarTech 52 burgeoning grievous 52 systemic RNAi therapeutic 52 Sepracor licensees 52 humanized antibody 52 insulin parathyroid hormone 52 BFPET 52 targeted biologic therapies 52 tramiprosate Alzhemed TM 52 inhibiting angiogenesis 52 A3 adenosine receptor 52 blockers angiogenesis inhibitors 52 vitro dissolution 52 generation rotary VAD 52 EP #R 52 immunotherapies 2A/Furin 52 ViiV Healthcare 52 Enanta Pharmaceuticals 52 E2F Decoy 52 DNA methylation biomarkers 52 PSN# [001] 52 selective kinase inhibitors 52 please visit www.rosettagenomics.com 52 biologic therapeutics 52 Curaxins 52 otelixizumab 52 Trofile TM 52 regenerative stem cell 52 OraQuick rapid 52 HuLuc# 52 sterile lidocaine patch 52 eTag assays 52 Bellicum Pharmaceuticals Inc. 52 Ligand proprietary 52 Phusion Laboratories 52 genotyping gene expression 52 thorough QTc 52 mitotic kinesins family 52 VersaFilm 52 Dr. Marlies Sproll 52 MOZOBIL 52 protein kinase inhibitors 52 predictive biomarkers 52 Protexia R 52 Pepducin 52 Azedra TM 52 compound KOS 52 INOmax R 52 GoldmanResearchGroup.com alerts investors 52 JAK1 52 VivaGel TM 52 TLR8 agonist 52 EECP ® therapy 52 novel RNAi therapeutics 52 genomics proteomics cellular 52 proven proprietary AcuForm 52 Biomoda www.biomoda.com 52 proprietary MSCRAMM R 52 neuro inflammatory disorders 52 JAK3 52 bardoxolone 52 PEG SN# 52 cytoskeletal pharmacology 52 LifeVantage Announces 52 methylation profiling 52 opioid bowel dysfunction 52 AQUA ® 52 develop PS# 52 Cerebril TM 52 RECOTHROM ® 52 Harry Palmin President 52 melanocortin receptor 52 proprietary chromatographic purification 52 Trofex 52 product platforms GVAX 52 oral interferon 52 visit www.bioject.com 52 DXL# 52 AtuRNAi 52 discovery anddevelopment 52 Muraglitazar 52 Uvidem 52 topical anti infective 52 Dr. Bahcall 52 cerebro cardiovascular disease 52 SGLT inhibitors 52 single molecule sequencing 52 intranasal formulation 52 hematological tumors 51 developing biomedical countermeasures 51 novel BiTE antibodies 51 thetreatment 51 noninvasive outpatient 51 immunotherapeutics 51 metabolomics driven 51 ViaCord R 51 CCX# 51 commercialize ZYFLO CR 51 orally bioavailable mimics 51 chimeric monoclonal antibody 51 Occlusin TM 51 radiotherapeutic 51 Colorectal Cancer CRC 51 orally bioavailable 51 platform Pentad ™ 51 Exherin TM 51 selectively inhibiting 51 TOCOSOL 51 vivo pharmacology 51 vaccine GRNVAC1 51 EHT AGN 51 Calypte believes 51 injectable interferon 51 commercialize elagolix 51 entinostat 51 AclarusDx 51 Modrenal 51 brentuximab 51 RNAi therapeutic targeting PCSK9 51 Brussels THR 51 oral tyrosine kinase 51 Catabasis 51 virology immunology 51 Ceflatonin R 51 IV RSD# 51 Arcelis TM 51 photodynamic therapy dermatology 51 AIDS malaria tuberculosis 51 UltiMAb R technology 51 ostarine 51 oncolytic viruses 51 Cellerant 51 VaxImmune 51 candidate Trofex TM 51 Relovair 51 Phase IIa proof 51 TKB# 51 Urocortin 2 51 generation FBPase inhibitor 51 receptor tyrosine kinase inhibitor 51 Qualified Person overseeing Lydian 51 orally dosed 51 Nalmefene 51 Onco TCS 51 PD2i ® algorithm 51 neurodegenerative diseases Alzheimer disease 51 chemokine receptor CCR1 51 IOC reanalyzed 51 hematological indications 51 CCR5 inhibitors 51 Onalta ™ 51 EMPOWER pivotal trial 51 bacillus Calmette Guerin BCG 51 proprietary phage display 51 psoriatic arthritis rheumatoid arthritis 51 Dr. Sékaly 51 Artificial pancreas 51 glucose sensing 51 outlicensing 51 NASDAQ PANC biotechnology 51 OTCBB NRGX biotechnology 51 epilepsy Parkinson disease 51 HyACT 51 RapidResponse TM DNA 51 Current Lm vaccines 51 NurOwn TM 51 diagnostic biomarker 51 MorphoSys Galapagos 51 uranium molybdenum rhenium 51 Loramyc TM 51 Optimata 51 Memryte 51 Triapine 51 London AiM GLPG 51 URG# 51 BACcelr8r TM 51 Rosetta Genomics microRNA 51 Novolimus 51 JAK3 inhibitor 51 AE# vaccine 51 PD2i CA Cardiac Analyzer 51 lipid nanoparticle LNP 51 OncoVEX GM CSF 51 Apoptone 51 Theratope 51 Biodefense Division 51 peptide fusion 51 Shigamabs R 51 validate biomarkers 51 XL# XL# 51 Antisoma fills 51 Fx #A 51 bowel cleansing prior 51 phage display technology 51 InoLife 51 regenerative therapeutics 51 Alequel ™ 51 deCODE Glaucoma TM 51 Onalta 51 Eligard R 51 midstage trials 51 Aplidin 51 oncolytic vaccine 51 Ms. Falberg 51 Zemiva TM Trofex TM 51 NexVas TM 51 initiate Phase IIb 51 Preotact 51 MEK inhibitors 51 RNAi therapeutic 51 isoform selective inhibitors 51 Biomerk Tumorgraft